4 Einträge gefunden

1. Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia

   1. Möker, Paula
   2. Zur Stadt, Udo
   3. Zimmermann, Martin
   4. Alawi, Malik
   5. Mueller, Stephanie
   6. Finger, Jasmin
   7. Knörr, Fabian

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

   1. Schramm, Franziska
   2. Zur Stadt, Udo
   3. Zimmermann, Martin
   4. Jorch, Norbert
   5. Pekrun, Arnulf
   6. Borkhardt, Arndt
   7. Imschweiler, Thomas

   2019 - Forschungsinformationssystem des UKE
3. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial

   1. Escherich, Gabriele
   2. Zur Stadt, Udo
   3. Zimmermann, Martin
   4. Horstmann, Martin A

   2013 - Forschungsinformationssystem des UKE
4. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

   1. Escherich, Gabriele
   2. Troeger, Anja F
   3. Gobel, Ulrich
   4. Graubner, Ulrike
   5. Pekrun, Arnulf
   6. Jorch, Norbert
   7. Kaspers, Gjl

   2011 - Forschungsinformationssystem des UKE - frei zugänglich